RESUMO
BACKGROUND: A significant proportion of cases of cardiogenic shock (CS) are due aetiologies other than acute coronary syndromes (non ACS-CS). We assessed differences regarding clinical profile, management, and prognosis according to the cause of CS among nonselected patients with CS from a large nationwide database. METHODS: We performed an observational study including patients admitted from the hospitals of the Spanish National Health System (SNHS) with a principal or secondary diagnosis code of CS (2016-2019). Data were obtained from the Minimum Basic Data Set (MBDS). Hospitals were classified according to the availability of cardiology related resources, as well as the availability of Intensive Cardiac Care Unit (ICCU). RESULTS: A total of 10,826 episodes of CS were included, of whom 5,495 (50.8%) were non-ACS related. Non ACS-CS patients were younger (71.5 vs. 72.4 years) and had a lower burden of arteriosclerosis-related comorbidities. Non ACS-CS cases underwent less often invasive procedures and presented lower in-hospital mortality (57.1% vs. 61%,p < 0.001). The most common main diagnosis among non ACS-CS was acute decompensation of chronic heart failure (ADCHF) (35.4%). A lower risk-adjusted in-hospital mortality rate was observed in high volume hospitals (52.6% vs. 56.7%; p < 0.001), as well as in centers with ICCU (OR: 0.71; CI 95%: 0.58-0.87; p < 0.001). CONCLUSIONS: More than a half of cases of CS were due to non-ACS causes. Non ACS-CS cases are a very heterogeneous group, with different clinical profile and management. Management at high-volume hospitals and availability of ICCU were associated with lower risk adjusted mortality among non ACS-CS patients.
Assuntos
Insuficiência Cardíaca , Choque Cardiogênico , Humanos , Choque Cardiogênico/epidemiologia , Choque Cardiogênico/etiologia , Choque Cardiogênico/terapia , Insuficiência Cardíaca/complicações , Prognóstico , Hospitais , Hospitalização , Mortalidade HospitalarAssuntos
Humanos , Masculino , Pessoa de Meia-Idade , Trombocitopenia/induzido quimicamente , Trombose/diagnóstico , Heparina/efeitos adversos , Vasos Coronários/patologia , Trombocitopenia/complicações , Trombose/etiologia , Heparina/administração & dosagem , Anticoagulantes/administração & dosagem , Anticoagulantes/efeitos adversosAssuntos
Tamponamento Cardíaco/terapia , Oxigenação por Membrana Extracorpórea/métodos , Miocardite/terapia , Choque Cardiogênico/terapia , Adulto , Humanos , Vírus da Influenza A/isolamento & purificação , Influenza Humana/complicações , Masculino , Miocardite/virologia , Choque Cardiogênico/etiologiaRESUMO
No disponible